Newtopia Inc. (NEWU.V)
| Previous Close | 0.1050 |
| Open | 0.1000 |
| Bid | 0.0800 x N/A |
| Ask | 0.1050 x N/A |
| Day's Range | 0.0900 - 0.1050 |
| 52 Week Range | 0.0200 - 0.2500 |
| Volume | |
| Avg. Volume | 50,852 |
| Market Cap | 15.584M |
| Beta (5Y Monthly) | -1.86 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0700 |
| Earnings Date | Apr 03, 2023 - Apr 07, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.40 |
- CNW Group
Newtopia Grants Incentive Options
Newtopia Inc. ("Newtopia" or the "Company") (TSXV: NEWU) (OTC: NEWUF), a tech-enabled habit change provider focused on preventing, slowing and reversing chronic disease, announces that its board of directors has granted incentive stock options to directors, officers and employees of the Company exercisable for 10,600,000 common shares of the Company at $0.105 per share for five years (the "Options"). The Options have been granted pursuant to the Company's amended and restated stock option plan d
- CNW Group
Newtopia Successfully Completes 2022 Renewal Cycle and Raises $1.5M on Road to Profitability in 2023
Newtopia Inc. ("Newtopia" or the "Company") (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled whole health platform creating sustainable habits that prevent, slow and reverse chronic disease, today announced that following the successful renewal of clients contracts from 2022, it has closed a non-brokered private placement of units of the Company (the "Units") at a price of $0.07 per Unit (the "Offering"). The Company intends to use the net proceeds of the Offering for general corporate and working ca
- CNW Group
Successful Newtopia and Medtronic Lifestyle Intervention Pilot to Address Prevalence of Type 2 Diabetes Exceeds Expectations in Newfoundland and Labrador
Newtopia Inc. ("Newtopia" or the "Company") (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled whole health platform creating sustainable habits that prevent, slow and reverse chronic disease, today announced the success of a partnership with Medtronic Canada and the collaboration with Eastern Health to proactively prevent, slow and reverse Type 2 diabetes burden in Newfoundland and Labrador through an innovative, value-based approach.
